Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

  • Smoking Cessation Experts Applaud New Cigarette Labeling
    11/10/10
    University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
  • UB School of Nursing Celebrates its 75th Anniversary
    11/10/10
    In 1936, at a time when 125 out of every 1,000 Americans were high school graduates and 23 out of every 1,000 Americans were college graduates, the Division of Nursing within the University at Buffalo's School of Medicine was established. Four years later, it became independent, making it the university's 12th school.
  • Big Hopes, Small Pharma: UB Spin-Off Wins FDA Orphan Designation for Drug made from Tarantula Venom
    11/9/10
    As Rose Pharmaceuticals marks its first anniversary this month, the stockbroker and University at Buffalo researchers who founded the company are celebrating a year of accomplishments.
  • To Promote HIV Research in Africa, NIH Awards UB Pharmacology Lab $2.3 Million
    11/8/10
    For more than 10 years, the University at Buffalo's HIV Clinical Pharmacology Research Program has helped fight the global AIDS epidemic by hosting visiting pharmaceutical scientists from countries like Zimbabwe and Nigeria in order to teach them how to conduct clinical trials and research on HIV/AIDS. Now, in recognition of their success and the need to expand these efforts, the National Institutes of Health has awarded a total of $2.3 million to the UB laboratory.
  • For Chinese Families, Alzheimer's Presents Unique Cultural Challenges
    11/8/10
    If dementia were a country, its economy would rank 18th between Turkey and Indonesia. The total estimated global cost of dementia in 2010 is slated to be $604 billion, according to Alzheimer's Disease International. The sharpest increase in the 35.6 million people across the world with dementia is now occurring in rapidly developing regions -- especially in China.
  • OncoMed Partners with UB to Meet Growing Demands in Oncology Pharmacy
    11/5/10
    When one of the nation's largest providers of oncology pharmacy services, OncoMed, decided to expand from a New York City suburb into a new facility on the Buffalo Niagara Medical Campus last month, an important factor was the potential to partner with the University at Buffalo.
  • Experience Rescuing Teenagers Caught in Sex Trafficking Motivates Student's Research
    11/4/10
    When University at Buffalo School of Social Work doctoral candidate Bincy Wilson tried to rescue teenage women from sexual trade slavery working the streets of Goa, India, she was the frequent target of threats made by the pimps -- some of them family members of the women -- whose livelihood relied on keeping these women in sexual servitude.
  • Cancer Drug Linked to Quantum Dots Increases Drug Uptake, Reduces Inflammatory Response, UB Researchers Show
    11/1/10
    Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
  • Dean of UB Dental School Recognized for Innovative Approach to Dentistry
    11/1/10
    Michael Glick, DMD, professor and dean of the UB School of Dental Medicine, has been awarded the Edward B. Shils Entrepreneurial Education Award and the American Dental Education Association's William J. Gies Foundation First Place Editorial Award (ADEA GIES).
  • Effects of Low Testosterone in Young Type 2 Diabetics to be Studied
    10/29/10
    An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.